Filing Details
- Accession Number:
- 0001209191-11-002931
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-01-12 16:11:38
- Reporting Period:
- 2011-01-10
- Filing Date:
- 2011-01-12
- Accepted Time:
- 2011-01-12 16:11:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1131324 | Genomic Health Inc | GHDX | Services-Medical Laboratories (8071) | 770552594 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1337801 | W Randal Scott | 301 Penobscot Drive Redwood City CA 94403 | Executive Chairman | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2010-12-29 | 20,000 | $0.00 | 1,660,646 | No | 5 | G | Direct | |
| Common Stock | Disposition | 2010-12-29 | 7,000 | $0.00 | 1,653,646 | No | 5 | G | Direct | |
| Common Stock | Disposition | 2010-12-29 | 7,000 | $0.00 | 1,646,646 | No | 5 | G | Direct | |
| Common Stock | Disposition | 2011-01-10 | 10,000 | $21.75 | 1,636,646 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2011-01-11 | 10,000 | $21.71 | 1,626,646 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | G | Direct | |
| No | 5 | G | Direct | |
| No | 5 | G | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 12,298 | Indirect | By Morgan Stanley DW Inc. as Custodian for Randal W. Scott, IRA |
| Common Stock | 3,466 | Indirect | Held in trust for the benefit of Dr.Scott's children, of which Dr. Scott's sister is trustee. |
Footnotes
- This sale of common stock was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 7, 2009.
- Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- Represents weighted average sale price. Actual sale prices ranged from $21.47 to $21.86.
- Represents weighted average sale price. Actual sale prices ranged from $21.46 to $21.93.
Billionaire Hedge Funds
